Posts by Charlie Schmidt
Men whose PSA levels continue rising even after surgery or radiation therapy may have a new treatment option with the approval of the drug apalutamide.
Men with prostate cancer that has spread outside the gland now have several newer drug options available for treatment, and research has found that taking any of them is likely to improve survival duration.
Surveys of over 900 men who were diagnosed with prostate cancer in the 1990s found that approximately 15% had some regret over their treatment choices. Study authors encourage doctors and patients to have frank and thorough discussions about about the risks and benefits of various forms of treatment for prostate cancer.
In contrast to earlier research, a review of dozens of studies involving millions of men who had vasectomies found no proof that having a vasectomy increases a man’s risk of prostate cancer.
The results of two studies found that using the drug abiraterone in combination with other hormonal therapy drugs to treat aggressive prostate cancer produced more favorable results than the first-line therapy alone.
Men who participated in yoga classes twice a week while being treated for prostate cancer reported less fatigue and better urinary and erectile function, compared to other men in the study who did not do yoga.
A small pilot study that combined surgery, radiation, and hormone therapy may lead to future treatment options for men with prostate cancer that has spread beyond the gland.
For men who have had prostate gland removal surgery, results from a new study show that a combination of radiation treatment and androgen deprivation therapy is more effective for treating PSA recurrence than radiation alone.
In a British study, a specialized type of MRI test did significantly better at identifying high-grade prostate tumors than a transrectal ultrasound biopsy. It’s hoped that one day this test might help men avoid prostate biopsies and their potential complications.
After prostate cancer surgery, the patient’s prostate-specific antigen (PSA) is monitored by his doctor via a simple blood test. New research indicates that if the PSA increases following surgery, immediate radiation therapy can reduce the risk of cancer recurrence.